Novavax (NVAX) Operating Margin (2010 - 2026)
Novavax (NVAX) posted quarterly Operating Margin of 11.06% for Q1 2026, down 8839.0% year-over-year from 0.13% in Q1 2025, and down 214.36% quarter-over-quarter from 9.67% in Q4 2025.
Novavax (NVAX) Operating Margin (2010 - 2026) Analysis & Trends
Novavax's Operating Margin history runs 17 years deep, the most recent figure standing at 11.06% for Q1 2026.
- In Q1 2026, Operating Margin fell 8839.0% year-over-year to 11.06%; the TTM figure through Mar 2026 stood at 14.69% (down 4747.0% YoY), while the FY2025 annual figure was 40.3%, up 7679.0% from the prior year.
- Operating Margin for Q1 2026 stood at 11.06%, down from 9.67% in the prior quarter.
- The five-year high for Operating Margin was 77.33% in Q1 2025, with the low at 386.37% in Q1 2023.
- The 5-year median for Operating Margin is 63.01% (2023), against an average of 80.04%.
- The sharpest annual moves came in 2022 and 2023: Operating Margin surged 30304 bps in 2022, then tumbled 41610 bps in 2023.
- Novavax's Operating Margin stood at 68.24% in 2022, then grew by 8 bps to 63.01% in 2023, then tumbled by 136 bps to 148.43% in 2024, then surged by 107 bps to 9.67% in 2025, then slumped by 214 bps to 11.06% in 2026.
- Business Quant data shows NVAX's Operating Margin at 11.06% in Q1 2026, 9.67% in Q4 2025, and 252.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | -96.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -96.84% |
| Mar 31, 2026 | -11.06% |
| Dec 31, 2025 | 9.67% |
| Sep 30, 2025 | -252.70% |
| Jun 30, 2025 | 57.75% |
| Mar 31, 2025 | 77.33% |
| Dec 31, 2024 | -148.43% |
| Sep 30, 2024 | -158.58% |
| Jun 30, 2024 | 38.75% |
| Mar 31, 2024 | -154.31% |
| Dec 31, 2023 | -63.01% |
| Sep 30, 2023 | -67.19% |
| Jun 30, 2023 | 13.07% |
| Mar 31, 2023 | -386.37% |
| Dec 31, 2022 | -68.24% |
| Sep 30, 2022 | -17.31% |
| Jun 30, 2022 | -259.76% |
| Mar 31, 2022 | 29.73% |
| Dec 31, 2021 | -371.27% |
| Sep 30, 2021 | -171.74% |